ArticleCureus2025
Unconventional Management of Partial Placenta Accreta for Uterine Preservation: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present the case of a 35-year-old G2P1102 who underwent a unique approach to managing partial placenta accreta for uterine preservation. The patient was diagnosed with atypical hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome and subsequently underwent a repeat cesarean delivery at 36 weeks of gestation. Intraoperatively, approximately 5% of the placenta was determined to remain adherent to the uterine cavity. Initial attempts at complete placental removal were unsuccessful. After hemostasis was obtained, it was decided that the patient would undergo expectant management with close observation. At the six-week postpartum appointment, retained products of conception were suspected, contributing to ongoing uterine bleeding. Hysteroscopic tissue resection and dilation, and curettage were used to remove remnant placental tissues, then the Mirena intrauterine device (IUD) was inserted at the end. The procedure was successful, preserving the uterus and resolving the patient's bleeding. This case highlights a potential alternative approach to managing partial placenta accreta. Further research is needed to evaluate the efficacy and safety of this method in broader clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.